---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027270"
form_type: "8-K"
ticker: "AZTR"
cik: "0001701478"
company_name: "Azitra, Inc."
filed_at: "2026-06-04T20:10:29+00:00"
generated_at: "2026-06-04T20:42:58.516211+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Azitra adjourns 2026 annual meeting; only 17% of shares voted, needs 33.3% quorum

## Summary
- Meeting reconvened to June 15, 2026 at 11:00 a.m. ET; record date remains April 24, 2026.
- Proxies received represented approx. 17% of outstanding shares; quorum requires 33⅓%.
- No changes to proposals; stockholders can vote by mail, Internet, or phone until June 15 at 10:59 a.m. ET.
- Company is a clinical-stage biopharma focused on precision dermatology; lead program ATR-12 for Netherton syndrome.

## SEC filing metadata
- accession: 0001493152-26-027270
- form_type: 8-K
- ticker: AZTR
- cik: 0001701478
- company_name: Azitra, Inc.
- filed_at: 2026-06-04T20:10:29+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701478/000149315226027270/0001493152-26-027270-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701478/000149315226027270/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027270
- JSON: https://secwatch.observer/filing/0001493152-26-027270.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027270.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.